Eckert J, Jacquier P, Baumann D, Raeber P A
Institut für Parasitologie, Universität Zürich.
Schweiz Med Wochenschr. 1995 Oct 21;125(42):1989-98.
In a retrospective study (1984-1992), new cases of human echinococcosis were registered in Switzerland based on information obtained from (a) questionnaires sent to 294 of the 300 acute hospitals in all parts of the country and to 17 institutes of pathology (268 answers form hospitals: 91%), and (b) from tracing back cases reported under the official notification system since 1 January 1988 by laboratories to the Federal Health Office or recorded at the Institute of Parasitology in Zurich. Cases were regarded as verified if the diagnosis was documented by unequivocal findings (by radiology, ultrasonography, pathomorphology etc. and often by additional detection of anti-Echinococcus antibodies). Patients with antibodies but without reports on further findings were classified as suspected cases. From 1984 to 1992 (9 years), 302 new cases of human echinococcosis were diagnosed in Switzerland and verified in this study, corresponding to an annual average of 34 new cases and a range between 26 and 43 cases. The total number of 302 cases included 228 (75%) of cystic echinococcosis (CE) (Echinococcus granulosus), 65 (22%) of alveolar echinococcosis (AE) (E. multilocularis), and 9 (3%) of non-specified echinococcosis (NSE) (Echinococcus sp.). Among 185 patients with CE and 60 patients with AE and known geographic origin, the ratio of Swiss nationals to foreigners was 25%:75% and 88%:12% respectively. Based on a total population (Swiss nationals and foreigners) of 6.62 million in 1988 and the case numbers of 1984-1992, the following average annual incidence rates per 100,000 inhabitants were calculated: 0.51 for all new cases, 0.38 for CE, 0.11 for AE and 0.01 for NSE. In the 37 years since 1956 there has been steady increase in new cases of CE due to the importation of such cases by foreigners, whereas the case numbers of AE have remained nearly constant with a range between 7 and 10 new cases per year. In our study 258 suspected seropositive patients were registered but not added to the total number of cases, due to the lack of further findings.
在一项回顾性研究(1984 - 1992年)中,瑞士根据以下信息记录了人类棘球蚴病的新病例:(a) 向该国各地300家急症医院中的294家以及17家病理研究所发送问卷(收到268份医院回复:回复率91%);(b) 追溯自1988年1月1日起实验室根据官方通报系统向联邦卫生局报告或在苏黎世寄生虫学研究所记录的病例。如果诊断有明确的检查结果(通过放射学、超声检查、病理形态学等,且常伴有抗棘球蚴抗体的额外检测)予以证实,则这些病例被视为确诊病例。仅有抗体但无进一步检查结果报告的患者被归类为疑似病例。1984年至1992年(9年)间,瑞士共诊断出302例新的人类棘球蚴病病例并在本研究中得到证实,年均新增病例34例,范围在26至43例之间。302例病例中,228例(75%)为囊型棘球蚴病(CE)(细粒棘球绦虫),65例(22%)为泡型棘球蚴病(AE)(多房棘球绦虫),9例(3%)为未明确类型的棘球蚴病(NSE)(棘球绦虫属)。在185例CE患者和60例AE患者且已知地理来源的病例中,瑞士籍与外籍患者的比例分别为25%:75%和88%:12%。根据1988年662万的总人口(瑞士籍和外籍)以及1984 - 1992年的病例数,计算出每10万居民的以下年均发病率:所有新病例为0.51,CE为0.38,AE为0.11,NSE为0.01。自1956年以来的37年里,由于外籍人员输入病例,CE新病例数稳步增加,而AE的病例数基本保持稳定,每年新增7至10例。在我们的研究中,登记了258例疑似血清反应阳性患者,但由于缺乏进一步检查结果,未计入病例总数。